Radiation with concomitant chemotherapy after surgery for breast carcinoma;Irradiation et chimiotherapie concomitantes apres chirurgie pour cancer du sein: Etude arcosein

Cancer/Radiotherapie

Volumn 2, Issue 5, 1998, Pages 469-474

  Calais, G ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Breast cancer; Concomitant chemotherapy; Radiation

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MITOXANTRONE; TAMOXIFEN; ANTINEOPLASTIC AGENT;

ALOPECIA; BLOOD TOXICITY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; SKIN NECROSIS; VOMITING; ADJUVANT THERAPY; BREAST TUMOR; FEASIBILITY STUDY; FEMALE; MASTECTOMY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; REVIEW; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE III; FEASIBILITY STUDIES; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032150476     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(98)80034-6     Document Type: Conference Paper

References (31)

1. 1 Bennet JM, Muss HB, Doroschow JH, Wolff S, Krementz ET, Cartwright K et al. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide and fluorouracil with doxorubicin cyclophosphamide and fluorouracil in the therapy of metastatic breast carcinoma. J Clin Oncol 1988 ; 6 : 1611-20
2. 2 Broger J, Keijser A. Conservative breast cancer treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 1987 ; 13 : 1173-7
3. 3 Bucholz TA, Griffin T, Moe RE, Ellis GK, Livingstone RB, Pelton J et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993 ; 26 : 23-35
4. 4 Buzzoni R, Bonadonna G, Valagussa P, Zambetti M. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin Oncol 1991 ; 9 : 2134-40
5. 5 Calais G, Serin D, Fourquet A, Bosset JF. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. preliminary results: acute toxicity and treatment compliance. Breast Cancer Res Treat 1997 ; 46 : 31
6. 6 Craig-Henderson I, Allegra JC, Woodcock T, Wolff S, Bryan S, Cartweight K et al. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously untreated patients with metastatic breast cancer. J Clin Oncol 1989 ; 7 : 560-71
7. 7 Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994 ; 12 : 447-53
8. 8 Early Breast Cancer Trialist's Collaborative Group. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy - 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992 ; 339 : 1-15 and 71-84
9. 9 Estorch M, Carnio D, Martinez L, Berna L, Torres C, Allonso C et al. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 anti-myosin monoclonal antibody studies. J Clin Oncol 1993 ; 11 : 1264-8
10. 10 Fischer B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985 ; 312 : 665-73
11. 11 Fischer B, Redmond C, Wickherham DL, Bowman D, Schipper H, Wolmark N et al. Doxorubicin-containing regimens for the treatment of stage II breast cancer: the national surgical adjuvant breast and bowel project experience. J Clin Oncol 1989 ; 7 : 572-82
12. 12 Fischer B, Brown AM, Dimitrov NV, Poisson R, Redmond C, Margolese R et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of CMF in positive node breast cancer patients with tamoxifen non responsive tumors: results from the national surgical adjuvant breast and bowel project B15. J Clin Oncol 1990 ; 8 : 1483-96
13. 13 Fischer B, Wickerham DL, Deutsch M, Anderson S, Redmond C, Fisher ER et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 1992 ; 8 : 153-60
14. 14 Fountzilas G, Polichronis A, Genatas S, Vasilaros S, Kosmidis P, Klourvas G et al. Cyclophosphamide + methotrexate + fluorouracil versus cyclophosphamide + mito-xantrone + fluorouracil as adjuvant treatment in node positive breast cancer. Proceed Am Soc Clin Oncol 1994 ; 13 : 111
15. 15 Harris JR, Recht A. Sequencing adjuvant chemotherapy and radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 1993 ; 26 : 183-5
16. 16 Hoogenraad WJ, Frasen JH, Van Turnhout JM. Enhanced toxicity of radiotherapy due to epirubicin containing adjuvant chemotherapy in breast carcinoma patients. Radiother Oncol 1992 ; 24 : 158
17. 17 Kimler BF, Handerson SD, Mansfield CM, Svoboda OJ, Cheng CC. Effect of mitoxantrone and thoracic irradiation on long term survival. Cancer Res 1982 ; 42 : 2656-9
18. 18 Lara-Jimenez P. Proceed 5th EORTC Breast Cancer Working Conference. Leuven 1991
19. 19 Mc Cormick B, Hakes T, Yahalom J, Kinne D, Norton L. Breast-conserving surgery and radiation: the delay of primary radiation after adjuvant chemotherapy does not influence local control. Proceed Am Soc Clin Oncol 1992 ; 11 : 47
20. 20 Misset JL, Delgado M, Chollet P, Belpomme D, Fargest P, Fumoleau P. Ten-years results of the french trial comparing adriamycin, vincristin, 5FU and cyclophosphamide to standard CMF as adjuvant therapy for node positive breast cancer. Proceed Am Soc Clin Oncol 1992 ; 11 : 41
21. 21 Nixon AJ, Rech A, Neuberg D, Conolly JL, Schnitt S, Abner A et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys 1994 ; 30 : 17-21
22. 22 Novak RF, Kharas CH. Mitoxantrone propensity for free radical formation and lipid peroxydation. Implications for cardiotoxicity. Invest New Drugs 1985 ; 3 : 95-9
23. 23 Overgaard M, Hansen P, Overgaard J, Rose C, Andersson M, Bach F et al. Postoperative radio-therapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New Engl J Med 1997 ; 337 : 949-55
24. 24 Pouillart P, Follezou JY, Palangie T, Feuilhade F, George C, Richards E. Long-term results of a randomized trial comparing regimens of cyclophosphamide and fluorouracil with either mitoxantrone or doxorubicin in patients with advanced breast cancer. Eur J Cancer 1994 ; 30 : 716-7
25. 25 Ragaz J, Jackson SM, Le N, Plenderleith I, Spinelli J, Bosco V et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New Engl J Med 1997 ; 337 : 956-62
26. 26 Recht A, Come S, Gelman R, Goldstein M, Tishler S, Gore SM. Integration of conservative surgery, radiotherapy and chemotherapy for the treatment of early-stage node-positive breast cancer: sequencing, timing and outcome. J Clin Oncol 1991 ; 9 : 1662-6
27. 27 Recht A, Come SE, Henderson CI, Gelman RS, Silver B, Hayes DF et al. Sequencing of chemotherapy (CT) and radiotherapy (RT) folowing conservative surgery for patients with early-stage breast cancer: results of a randomized trial. New Engl J Med 1996 ; 334 : 1356-61
28. 28 Reynaud-Bougnoux A, Mercier P, Descamps P, Le Floch O, Lansac J, Calais G. Postoperative radiotherapy and concomitant adjuvant chemotherapy for breast carcinoma. Proceed ECCO 8, Paris, 1995
29. 29 Robert J, Mornex F. Radiothérapie et chimiothérapie concomitantes des cancers. Aspects pharmacologiques. Bull Cancer Radiother 1993 ; 80 : 331-8
30. 30 Serin D, Aimard L, Kirscher S, Felix-Faure C. Chimiothérapie adjuvante FNC et radiothérapie concomitante dans les cancers du sein de stade II. Étude de faisabilité. Bull Cancer 1993 ; 80 : 541
31. 31 Slotman BJ. Hazards of delaying radiotherapy in breast conserving treatment. Eur J Cancer 1994 ; 30A : 5-7